TrialInternational journal of chronic obstructive pulmonary disease2015

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease.

Masakazu Ichinose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.